PhenoSenseGT gives you the complete picture of resistance. It is the only test that combines phenotype and genotype drug resistance data. Our updated report form is easy to read, user-friendly, and comprehensive. We have introduced upper and lower clinical cutoffs, along with a highly practical summary page. Even in complex cases, PhenoSenseGT brings clarity to your treatment choices.

The updated upper and lower clinical cutoffs reveal valuable treatment options, especially for patients with multi-drug resistance. A result above the upper cutoff indicates resistance. A result below the lower cutoff indicates sensitivity. A result between the cutoffs indicates partial susceptibility. PhenoSenseGT also includes data on replication capacity (RC), a novel marker that may indicate the aggressive nature (fitness) of a patient's virus.

While sophisticated in its technology, PhenoSenseGT remains user-friendly. One easy-to-read report features side-by-side actual phenotype and genotype results taken from a single patient sample. This comprehensive test allows for advanced, practical insight into the resistance continuum, and overcomes limitations associated with either genotyping or phenotyping alone.

Together with PhenoSense® Integrase and PhenoSense Entry®, PhenoSenseGT provides the most complete picture of resistance to antiretroviral medications.